This site is intended for healthcare professionals
Photo of Prostate cancer cells under microscope, pink and purple tones.
Prostate Cancer Nexus

Gerhardt Attard

Last updated: 11th Feb 2026
Published: 11th Feb 2026

Gerhardt Attard

Gerhardt Attard, MD, PhD, FRCP

Gerhardt Attard is the John Black Charitable Foundation Chair in Urological Cancer Research at University College London (UCL), UK. He leads the Treatment Resistance Group at the UCL Cancer Institute and is a Consultant Medical Oncologist at UCL Hospital. Gerhardt is also an experienced clinical trialist and co-author of over 250 peer-reviewed publications. His research focuses on treatment resistance and precision medicine in advanced prostate cancer.

Disclosures: Advisor and lecturer for AACR, Agilent, Cancer Research UK, and the Prostate Cancer Foundation.

View content featuring Attard:

BRCA: Mapping the mCRPC genetic landscape

Complete the form below to receive our regular round-up of the latest clinical news and medical education resources on Medthority, straight to your inbox.

* = required information 

 

By providing your email address, you are opting in to receive our monthly newsletter.

By submitting this form you agree to our Terms of Use and Privacy Policy. You can withdraw your consent at any time by clicking the ‘unsubscribe’ link found at the bottom of every email.

Welcome: